Searle Company Ltd
Tahir Ahmed is an experienced professional in the pharmaceutical industry, currently serving as Managing Director at The Searle Company Limited since July 2022. Previously, Tahir held multiple roles at Searle Pakistan Limited, including Chief Operating Officer, Senior Business Manager, and Business Manager, where responsibilities included managing marketing budgets and delivering marketing activities. During tenure at Searle Pak Limited, Tahir revitalized the brand Calan and successfully re-launched Sustac, achieving significant market position. Educationally, Tahir is pursuing an Executive Education Program at Harvard Business School and holds an MBA in Pharmaceutical Business Management from Bahria University, along with a degree from Karachi University.
This person is not in any teams
This person is not in any offices
Searle Company Ltd
The Searle Company Limited is a holding company, which is principally engaged in the manufacture of pharmaceutical products and other consumer products. In addition, the Company is engaged in sale of food and consumer products, and manufacture of pharmaceutical products for other companies. The Company operates through three segments: Pharma, Consumer and Investment property. The Company's geographical segments include Pakistan, South Asia, East Africa, South-East Asia and Middle East. The Company's portfolio includes three divisions: Pharma, Consumer Health and Nutrition. Its products include Selanz SR, Levoxin, Lomotil, Xaroban, Vitrum, Rhulef, Canderel, Peditral, Ezium, Hydryllin, Xadine, Zenbar, Extor, Adronil, Nuberol/Nuberol Forte and Byscard. The Company has pharmaceutical range across therapeutic areas, such as cardiovascular, respiratory care, gastroenterology, pain management, orthocare, neuropsychiatry, probiotics, antibiotics and nutritional care.